Research at our BRC is designed and operationally structured to optimise the delivery of translational innovation for patient benefit.
Our research spans across eight themes based on a track record of scientific and clinical excellence. For operational delivery our research is organised into five multidisciplinary groupings known as clusters, which are underpinned by our research platforms and other infrastructure.
Our research aims
We drive interdisciplinary translational research innovation across our disease-based themes and tackle some of the world’s biggest healthcare challenges by bringing together clinical and scientific excellence from a range of disciplines. The BRC continually seeks to:
- expand and push forward our translational research pipeline across a wide range of diseases and conditions;
- invest in the latest technologies to develop state-of-the-art facilities for patient based experimental studies;
- develop future leaders in translational medicine by creating an environment that provides excellence in training, education and capacity building;
- engage actively with our diverse local population, partners and stakeholders; and
- disseminate the outcomes of our research to demonstrate how we are successfully driving new treatments and improvements in patient care.
Facilities and technologies
Our researchers are at the forefront of translational research through investment in research platforms and technologies. For instance The Immune Monitoring Flow Cytometry research platform has recently added the first UK CyTOF mass cytometer that allows our investigators to stay at the forefront of highly multiplexed biomarker discovery.
Training programmes and fellowships
Our innovative training programmes and fellowships nurture translational research capability and capacity. Many of our clinical training fellows have gone on to win highly competitive research funding awards from external organisations such as the Wellcome Trust, Medical Research Council and British Heart Foundation.
Our consultancy services support translational researchers at all stages of their studies. They span data management, bioinformatics, statistical advice, planning research proposals and user involvement.
Our high profile collaborations and partnerships strengthen and validate our translational research. They include the Cell Therapy Catapult, Quintiles, BD Biosciences , Illumina, Pfizer and King’s Health Partners Academic Health Science Network.
Peer reviewed publications
Our BRC has published over 1180 peer-reviewed publications in high impact journals since 2012 .
Under the NIHR Biomedical Research Centre contract awarded for funding, we are contractually bound to be monitored by key performance indicators and metrics on research outputs. We are currently in the process of bidding for a third NIHR BRC funding award for 2017 to 2022.